Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

ea0056n1.1 | (1) | ECE2018

Abstract unavailable....

ea0056n1.2 | (1) | ECE2018

Abstract unavailable....

ea0056n1.3 | (1) | ECE2018

Abstract unavailable....

ea0056n2.1 | (1) | ECE2018

Abstract unavailable....

ea0056n2.2 | (1) | ECE2018

Abstract unavailable....

ea0056n2.3 | (1) | ECE2018

Abstract unavailable....

ea0056n2.4 | (1) | ECE2018

Abstract unavailable....

ea0056n3.1 | (1) | ECE2018

Nursing Management of Congenital Adrenal Hyperplasia (CAH): - Education, Managment and use of Multi-Media Technology

Mitchelhill Irene

Introduction: The management of Congenital Adrenal Hyperplasia (CAH) requires specific expertise and understanding in childhood, adolescence and adulthood. Patient education and support is an integral part of this health care process, from the delivery of a diagnosis and explanation by medical staff to the more detailed education provided by nurses in order to help families understand the practical aspects of management.Background: For parents, the initi...

ea0056n4.1 | (1) | ECE2018

Abstract unavailable....

ea0056n4.2 | (1) | ECE2018

Abstract unavailable....

ea0056n4.3 | (1) | ECE2018

Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance testing with two different doses (0.15 vs 0.10 U/kg)

Yeoh Phillip

The Insulin Tolerance Test (ITT) is the gold standard test to assess growth hormone (GH) and ACTH reserve. This dynamic test induces hypoglycaemia and is commonly performed by endocrine nurses using different insulin doses -commonly 0.15 U or 0.10 U/kg. As part of a quality and safety improvement initiative we conducted a retrospective study to address several questions relating to ITT insulin dose. ITT results (n=148) were retrieved from two large endocrine testing c...

ea0056n4.4 | (1) | ECE2018

Cooperation between an endocrine nurse, psychologist and physician and their role in the care of depression in patients treated with multi kinase inhibitors due thyroid cancer

Rozanska Alina

The treatment with multi kinase inhibitors (MKI) under clinical trials due to advanced thyroid cancer (TC) may postpone moving on the patients with advanced disease to the palliative care stage. However, chronic and escalating somatic symptoms during the treatment may promote the appearance of depressive reactions. It can be expected that a cognitive image of the disease, as a collection of subjective beliefs concerning patientÂ’s own illness and treatment, will be an impo...

ea0056n4.5 | (1) | ECE2018

Abstract unavailable....